Wang Lai Insider Trading Activity
Wang Lai has been net-selling over the last 12 months with 0 purchases and 6 sales across 1 company.
ONC is the most-traded position with 6 trades. The largest single transaction was a sale of ONC for $1.8M on Sep 9, 2025.
Performance Scorecard
Forward stock performance after each transaction by Wang Lai. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -2.8% | 54% | 13 |
| 90 days | — | -15.2% | 8% | 12 |
| 120 days | — | -20.6% | 8% | 12 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersONC · BeOne Medicines Ltd.
🔒 Subscribe to see trade entries
Pro members see exactly when Wang Lai bought and sold ONC.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jun 23, 2026 | ONC | Sell | 1,068 | $276.74 | $296K | −100.0% | President | |
Sep 9, 2025 | ONC | Sell | 5,000 | $350.06 | $1.8M | −100.0% | Global Head of R&D | |
Jul 30, 2025 | ONC | Sell | 259 | $305.00 | $79K | −100.0% | Global Head of R&D | |
Jul 29, 2025 | ONC | Sell | 800 | $304.16 | $243K | −75.5% | Global Head of R&D | |
Jul 29, 2025 | ONC | Sell | 292 | $302.92 | $88K | −21.6% | Global Head of R&D | |
Jul 29, 2025 | ONC | Sell | 2,949 | $302.00 | $891K | −68.6% | Global Head of R&D | |
Jul 18, 2025 | ONC | Sell | 700 | $300.00 | $210K | −100.0% | Global Head of R&D | |
Jun 23, 2025 | ONC | Sell | 1,028 | $260.00 | $267K | −100.0% | Global Head of R&D | |
Jun 17, 2025 | ONC | Sell | 470 | $251.37 | $118K | −100.0% | Global Head of R&D | |
Jun 16, 2025 | ONC | Sell | 1,177 | $266.40 | $314K | −71.5% | Global Head of R&D | |
Jun 6, 2025 | ONC | Sell | 600 | $250.71 | $150K | −42.8% | Global Head of R&D | |
Jun 6, 2025 | ONC | Sell | 202 | $251.89 | $51K | −25.2% | Global Head of R&D | |
Jun 6, 2025 | ONC | Sell | 300 | $253.19 | $76K | −50.0% | Global Head of R&D |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| ONC | BeOne Medicines Ltd. | 13 | $4.5M |
Other insiders at BeOne Medicines Ltd.
5 other tracked filers at ONC.